550 related articles for article (PubMed ID: 2174659)
21. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.
Barr LF; Campbell SE; Diette GB; Gabrielson EW; Kim S; Shim H; Dang CV
Cancer Res; 2000 Jan; 60(1):143-9. PubMed ID: 10646866
[TBL] [Abstract][Full Text] [Related]
22. [Biology of small-cell bronchogenic carcinoma: recent advances].
Levy R; Andrieu JM; Even P
Bull Cancer; 1992; 79(1):25-46. PubMed ID: 1325850
[TBL] [Abstract][Full Text] [Related]
23. Molecular abnormalities in lung cancer.
Salgia R; Skarin AT
J Clin Oncol; 1998 Mar; 16(3):1207-17. PubMed ID: 9508209
[TBL] [Abstract][Full Text] [Related]
24. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.
Takahashi T; Obata Y; Sekido Y; Hida T; Ueda R; Watanabe H; Ariyoshi Y; Sugiura T; Takahashi T
Cancer Res; 1989 May; 49(10):2683-8. PubMed ID: 2540905
[TBL] [Abstract][Full Text] [Related]
25. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
[TBL] [Abstract][Full Text] [Related]
26. Oncogenes and a specific chromosomal abnormality associated with small-cell lung cancers.
Taya Y
Jpn J Clin Oncol; 1986 Sep; 16(3):199-202. PubMed ID: 3022029
[TBL] [Abstract][Full Text] [Related]
27. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.
Pavelic K; Antonic M; Pavelic L; Pavelic J; Pavelic Z; Spaventi S
Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516
[TBL] [Abstract][Full Text] [Related]
28. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene.
Johnson BE; Battey J; Linnoila I; Becker KL; Makuch RW; Snider RH; Carney DN; Minna JD
J Clin Invest; 1986 Aug; 78(2):525-32. PubMed ID: 3016030
[TBL] [Abstract][Full Text] [Related]
29. Co-amplification of a novel cyclophilin-like gene (PPIE) with L-myc in small cell lung cancer cell lines.
Kim JO; Nau MM; Allikian KA; Mäkelä TP; Alitalo K; Johnson BE; Kelley MJ
Oncogene; 1998 Aug; 17(8):1019-26. PubMed ID: 9747881
[TBL] [Abstract][Full Text] [Related]
30. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
31. Growth factors and cancer.
Goustin AS; Leof EB; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1015-29. PubMed ID: 3002607
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.
Schneider PM; Hung MC; Chiocca SM; Manning J; Zhao XY; Fang K; Roth JA
Cancer Res; 1989 Sep; 49(18):4968-71. PubMed ID: 2569928
[TBL] [Abstract][Full Text] [Related]
33. [C-myc activation by translocation in human primary non-small cell lung cancer].
Lu Y; Cheng S; Guo S
Zhonghua Yi Xue Za Zhi; 1996 Apr; 76(4):275-7. PubMed ID: 8758273
[TBL] [Abstract][Full Text] [Related]
34. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M
Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339
[TBL] [Abstract][Full Text] [Related]
35. Oncogenes and antioncogenes in lung tumorigenesis.
Giaccone G
Chest; 1996 May; 109(5 Suppl):130S-134S. PubMed ID: 8635391
[TBL] [Abstract][Full Text] [Related]
36. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization.
Kubokura H; Tenjin T; Akiyama H; Koizumi K; Nishimura H; Yamamoto M; Tanaka S
Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259
[TBL] [Abstract][Full Text] [Related]
37. myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer.
Västrik I; Mäkelä TP; Koskinen PJ; Saksela K; Alitalo K
Princess Takamatsu Symp; 1991; 22():307-18. PubMed ID: 1668890
[TBL] [Abstract][Full Text] [Related]
38. Rearrangement and co-amplification of L-myc and rlf in primary lung cancer.
Mäkelä TP; Shiraishi M; Borrello MG; Sekiya T; Alitalo K
Oncogene; 1992 Mar; 7(3):405-9. PubMed ID: 1312699
[TBL] [Abstract][Full Text] [Related]
39. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
40. [Recent progress in the biology of small cell bronchial carcinoma].
Thomas F; Arriagada R; Le Chevalier T; Poupon MF
Rev Mal Respir; 1988; 5(5):451-61. PubMed ID: 2847257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
